MESOBLAST LIMITED revenue breakdown overview

MESOBLAST LIMITED revenue for the last year amounted to 11.26 M AUD, the most of which — 11.15 M AUD — came from its highest performing source at the moment, Adult Stem Cell Technology, the year earlier bringing 14.08 M AUD. The greatest contribution to the revenue figure was made by Australia, United States and Singapore — last year it brought MESOBLAST LIMITED 11.15 M AUD, and the year before that — 14.08 M AUD.